disease progression
432 results
1 - 100
disease progression
ivosidenib- atezolizumab
- entrectinib
- dabrafenib
- lenvatinib
- trametinib
- larotrectinib
- PAZOPanib
- nivolumab
- acalabrutinib
- avapritinib
- tucatinib
- cabozantinib
- disease trajectory
- pomalidomide
- osimertinib
- time to progression
- ramucirumab
- crizotinib
- inavolisib
- ripretinib
- lorlatinib
- alpelisib
- venetoclax
- abemaciclib
- elacestrant
- vemurafenib
- binimetinib
- ibrutinib
- progression
- tisotumab vedotin
- datopotamab deruxtecan
- DOXOrubicin, liposomal
- progression-free
- alendronate
- darolutamide
- avelumab
- tiludronate
- bevacizumab
- bone resorption inhibitors
- exemestane
- macitentan
Arthrogram- copanlisib
- cetuximab
- lapatinib
- anastrozole
- selexipag
- SORAfenib
- vismodegib
- rucaparib
- dacomitinib
- adagrasib
- futibatinib
- olutasidenib
- eflornithine (systemic)
- interferon gamma-1b
- axitinib
- cemiplimab
- capivasertib
- idelalisib
- belzutifan
- capmatinib
- ensartinib
- tepotinib
- lazertinib
- fulvestrant
- temozolomide
- enfortumab vedotin
- ipilimumab
Paget Disease- ado-trastuzumab
- trabectedin
- niraparib
- lurbinectedin
- DAUNOrubicin citrate liposome
- ribociclib
- ziv-aflibercept
- enasidenib
- sirolimus (protein bound)
- panitumumab
- afatinib
- erdafitinib
- everolimus
- pembrolizumab
- olaparib
- fludarabine
- infigratinib
- dasatinib
- selinexor
- duration of response
- Albumin, Urine and Albumin/Creatinine Ratio (ACR)
- pemigatinib
- alectinib
- efgartigimod alfa/hyaluronidase
- belinostat